Kessler has always been in the business of keeping people healthy but by his own admission, he hasn't always applied that to himself
Clin Invest Med 2016;39:E48e62
Other combinations of entero-pancreatic hormones, including cagrisema (GLP-1/amylin RA) and the triple agonist retatrutide (GLP-1/GIP/glucagon RA), have progressed to phase 3 trials as obesity treatments, and early data suggest that they may lead to even greater weight loss than tirzepatide [28]
When you stop the medication, appetite tends to return, and without the pharmacological appetite suppression, a significant portion of lost weight typically comes back unless behavioral habits are strongly maintained
If youre considering any GLP-1 medication, start with a clinician who understands the science, not marketing hype
A compounded drug can be prescribed for a patient-specific medical need, but it is not an FDA-approved generic